Industry Updates banner

Industry Updates

Industry Updates

Staying up-to-date on the latest industry news and trends is critical to understanding the changing demands, technologies, regulations and compliance standards that come with pharmaceutical development, manufacturing and product launching. These are just a few of the leading sources of information to check periodically for seminars and other events, new tech and tools of the trade, and news, both in the U.S. and throughout the world.

Pharma Manufacturing RSS Feed for pharmamanufacturing.com

India's Glenmark to launch US spin-off
on February 15, 2019 at 4:50 pm

Generic drugmaker Glenmark Pharmaceuticals plans to spin off its innovation business into a new company in the U.S. […]


Internal rap video adds to Insys woes in opioid trial
on February 14, 2019 at 10:06 pm
During the racketeering trial for Insys Therapeutics founder, federal prosecutors shared a five-minute in-house rap […]

Singing the Praises of Lab Safety
on February 14, 2019 at 5:04 pm
Lab safety is no joke, but this parody is too good to pass u […]

FDA issues first warning letter under DSCA for opioid distribution
on February 13, 2019 at 8:47 pm
McKesson Corp is back in the spotlight for opioid-related violations — this time involving rules under the 2013 […]

Antidepressant made with party drug gets FDA panel’s backing
on February 13, 2019 at 8:45 pm
An experimental nasal spray developed by Johnson & Johnson to treat depression could be headed for FDA approval. […]

Patent Docs Patent Law Weblog

USPTO Extends One Pilot Program But Declines to Extend Another
by Patent Docs on February 18, 2019 at 5:59 am
By Donald Zuhn -- Last month, in Federal Register notices published on the same day (84 Fed. Reg. 411), the U.S. Patent […]

Conference & CLE Calendar
by Patent Docs on February 18, 2019 at 5:04 am
February 19, 2019 - Post-argument discussion on the Return Mail Inc. v. United States Postal Service case (American […]

Washington College of Law Post-Argument Discussion of Return Mail Inc. v. United States Postal Service
by Patent Docs on February 17, 2019 at 4:18 am
As part of its ongoing Supreme Court series, the American University Washington College of Law Program on Information […]

JMLS Presentation on the Effect of Patents on Innovation
by Patent Docs on February 17, 2019 at 4:17 am
The John Marshall Law School Center for Intellectual Property, Information & Privacy Law will be hosting Prof. […]

USPTO to Hold TC 2600 Customer Partnership Meeting
by Patent Docs on February 17, 2019 at 4:16 am
The U.S. Patent and Trademark Office will be holding a customer partnership meeting of Technology Center 2600 from 8:30 […]

Pharmavoice Read. Think. Participate.

Executive Perspective: A Fused Model for the Enterprise – A Conversation with Brian Williams
by Dan Limbach on February 13, 2019 at 3:04 pm
See the results of a Forrester study on digital transformation http://bit.ly/0219-Executive Winning in today’s […]

Content that Clicks: Syneos Health Publishes Report on Social Media Marketing for Clinical Trial Recruitment
by Dan Limbach on January 22, 2019 at 10:15 pm
75% of Americans seek medical information online at least once a month—and yet, just 11% of clinical trials […]

Health Mindsets Report from Syneos Health: How to Diversify Marketing Efforts According to Consumer Healthcare Attitudes
by Dan Limbach on January 16, 2019 at 1:04 am
That consumers are engaged with their own healthcare more now than ever before might make it all too easy to overlook […]

New report from Syneos Health Reveals Five Lessons about Reaching Caregivers: the Missing Link in Patient-Centricity
by Dan Limbach on January 11, 2019 at 8:50 pm
True patient-centricity—one of the biggest healthcare buzzwords for some time—now calls for accessing the […]

CDISC Legacy Data Conversion – a Case Study
by Dan Limbach on January 7, 2019 at 2:57 pm
Download now http://bit.ly/CDISC-ICON This recent case study by ICON outlines a project for a big pharma company. It […]

Drugs (Pharmaceuticals) News About Pharmaceuticals, Including Commentary and Archival Articles Published in the New York Times.

The Instant, Custom, Connected Future of Medical Devices
by JANET MORRISSEY on February 14, 2019 at 5:00 pm
3D-printed and “smart” pharmaceuticals are making medical treatments more effective. But it may take years […]

F.D.A. Panel Recommends New Depression Treatment
by BENEDICT CAREY on February 12, 2019 at 10:44 pm
The active ingredients of ketamine, a popular club drug, show promise in battling deep despair. […]

Trump Pledged to End H.I.V. But His Policies Veer the Other Way.
by ROBERT PEAR on February 12, 2019 at 10:02 pm
President Trump’s State of the Union pledge to end the scourge of H.I.V. was welcomed by AIDS activists, but it […]

Supplement Makers Touting Cures for Alzheimer’s and Other Diseases Get F.D.A. Warning
by SHEILA KAPLAN on February 11, 2019 at 4:43 pm
The agency warned 12 dietary supplement companies to stop marketing such products for disease treatments, and called […]

A New Treatment for a Painful Penis Curvature
by JANE E. BRODY on February 11, 2019 at 10:00 am
Encouraging men to seek help for Peyronie’s disease, a condition that can make sex difficult. […]

In the Pipeline Derek Lowe’s Commentary on Drug Discovery and the Pharma Industry. An Editorially Independent Blog From the Publishers of Science Translational Medicine.

India’s Disgrace
by Derek Lowe on February 15, 2019 at 2:11 pm
I’ve written here about what I referred to as “nationalist science”, in that case actions by the […]

Odd Peroxides Indeed
by Derek Lowe on February 14, 2019 at 3:01 pm
You know, normally when you start combining interesting or reactive functional groups in the same molecule, you end up […]

Vibrating Proteins, Resolved
by Derek Lowe on February 13, 2019 at 4:39 pm
Here’s something that many of us don’t tend to think about when we think about enzymes: vibrational energy. […]

The FDA and the Dietary Supplements
by Derek Lowe on February 12, 2019 at 1:25 pm
I’ve been complaining for years on this blog about the “dietary supplement” industry, which exists in […]

Virtual Screening – As Big As It Currently Gets
by Derek Lowe on February 11, 2019 at 3:13 pm
This new paper on “ultra-large” virtual screening is well worth a look in detail. We find a great many lead […]

Breaking World Pharma News World Pharma News - One of the World's Leading Web-Based Pharmaceutical News Publications - Is Committed to Providing and Disseminating the Most Prominent Pharmaceutical News and Achievements

Bayer exercised option to obtain full licensing rights for larotrectinib and BAY 2731954 (LOXO-195)
on February 15, 2019 at 9:00 am
Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology, to […]

FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain
on February 14, 2019 at 9:00 am
A key element of the U.S. Food and Drug Administration's mission is focused on helping to ensure that all products we […]

Researchers develop reversible antiplatelet therapy to fight clotting, cancer metastasis
on February 13, 2019 at 11:00 am
A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer […]

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announce first of its kind collaboration to integrate blockchain...
on February 12, 2019 at 11:00 pm
Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems […]

How Viagra puts a brake on a master growth regulator to treat heart disease
on February 12, 2019 at 11:00 am
When normal cells grow, divide or do any job in the body, they do so in response to a whole slew of internal sensors […]

EFC Pharma logo

Powering Your Most Profitable Relationships.


EFC Pharma proudly serves the pharmaceutical industry as the leading development, production, site transfer, and compliance specialists. Our relationships throughout the U.S and international markets allow us to facilitate the most profitable solution for your manufacturing and development obstacles. For further information about our production and development services, please contact us here.